These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 30139745)

  • 1. The non-enzymatic RAS effector RASSF7 inhibits oncogenic c-Myc function.
    Kumaraswamy A; Mamidi A; Desai P; Sivagnanam A; Perumalsamy LR; Ramakrishnan C; Gromiha M; Rajalingam K; Mahalingam S
    J Biol Chem; 2018 Oct; 293(40):15691-15705. PubMed ID: 30139745
    [No Abstract]   [Full Text] [Related]  

  • 2. MYC interaction with the tumor suppressive SWI/SNF complex member INI1 regulates transcription and cellular transformation.
    Stojanova A; Tu WB; Ponzielli R; Kotlyar M; Chan PK; Boutros PC; Khosravi F; Jurisica I; Raught B; Penn LZ
    Cell Cycle; 2016 Jul; 15(13):1693-705. PubMed ID: 27267444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Miz-1 and Max compete to engage c-Myc: implication for the mechanism of inhibition of c-Myc transcriptional activity by Miz-1.
    Bédard M; Maltais L; Montagne M; Lavigne P
    Proteins; 2017 Feb; 85(2):199-206. PubMed ID: 27859590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New structural determinants for c-Myc specific heterodimerization with Max and development of a novel homodimeric c-Myc b-HLH-LZ.
    Beaulieu ME; McDuff FO; Frappier V; Montagne M; Naud JF; Lavigne P
    J Mol Recognit; 2012 Jul; 25(7):414-26. PubMed ID: 22733550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myc phosphorylation in its basic helix-loop-helix region destabilizes transient α-helical structures, disrupting Max and DNA binding.
    Macek P; Cliff MJ; Embrey KJ; Holdgate GA; Nissink JWM; Panova S; Waltho JP; Davies RA
    J Biol Chem; 2018 Jun; 293(24):9301-9310. PubMed ID: 29695509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The MNT transcription factor autoregulates its expression and supports proliferation in MYC-associated factor X (MAX)-deficient cells.
    Lafita-Navarro MC; Liaño-Pons J; Quintanilla A; Varela I; Blanco R; Ourique F; Bretones G; Aresti J; Molina E; Carroll P; Hurlin P; Romero OA; Sanchez-Céspedes M; Eisenman RN; Delgado MD; León J
    J Biol Chem; 2020 Feb; 295(7):2001-2017. PubMed ID: 31919096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis.
    Diolaiti D; McFerrin L; Carroll PA; Eisenman RN
    Biochim Biophys Acta; 2015 May; 1849(5):484-500. PubMed ID: 24857747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MYC the oncogene from hell: Novel opportunities for cancer therapy.
    Papadimitropoulou A; Makri M; Zoidis G
    Eur J Med Chem; 2024 Mar; 267():116194. PubMed ID: 38340508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirt1 deacetylates c-Myc and promotes c-Myc/Max association.
    Mao B; Zhao G; Lv X; Chen HZ; Xue Z; Yang B; Liu DP; Liang CC
    Int J Biochem Cell Biol; 2011 Nov; 43(11):1573-81. PubMed ID: 21807113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Max b-HLH-LZ can transduce into cells and inhibit c-Myc transcriptional activities.
    Montagne M; Beaudoin N; Fortin D; Lavoie CL; Klinck R; Lavigne P
    PLoS One; 2012; 7(2):e32172. PubMed ID: 22384171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into the mechanism of heterodimerization from the 1H-NMR solution structure of the c-Myc-Max heterodimeric leucine zipper.
    Lavigne P; Crump MP; Gagné SM; Hodges RS; Kay CM; Sykes BD
    J Mol Biol; 1998 Aug; 281(1):165-81. PubMed ID: 9680483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMG-I/Y, a new c-Myc target gene and potential oncogene.
    Wood LJ; Mukherjee M; Dolde CE; Xu Y; Maher JF; Bunton TE; Williams JB; Resar LM
    Mol Cell Biol; 2000 Aug; 20(15):5490-502. PubMed ID: 10891489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene.
    Sharma N; Magistroni V; Piazza R; Citterio S; Mezzatesta C; Khandelwal P; Pirola A; Gambacorti-Passerini C
    Mol Cancer; 2015 Jul; 14():132. PubMed ID: 26179066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biophysical characterization of the b-HLH-LZ of ΔMax, an alternatively spliced isoform of Max found in tumor cells: Towards the validation of a tumor suppressor role for the Max homodimers.
    Maltais L; Montagne M; Bédard M; Tremblay C; Soucek L; Lavigne P
    PLoS One; 2017; 12(3):e0174413. PubMed ID: 28350847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myc interacts with Max and Miz1 to repress C/EBPdelta promoter activity and gene expression.
    Si J; Yu X; Zhang Y; DeWille JW
    Mol Cancer; 2010 Apr; 9():92. PubMed ID: 20426839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omomyc Reveals New Mechanisms To Inhibit the MYC Oncogene.
    Demma MJ; Mapelli C; Sun A; Bodea S; Ruprecht B; Javaid S; Wiswell D; Muise E; Chen S; Zelina J; Orvieto F; Santoprete A; Altezza S; Tucci F; Escandon E; Hall B; Ray K; Walji A; O'Neil J
    Mol Cell Biol; 2019 Nov; 39(22):. PubMed ID: 31501275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MSSP promotes ras/myc cooperative cell transforming activity by binding to c-Myc.
    Niki T; Izumi S; Saëgusa Y; Taira T; Takai T; Iguchi-Ariga SM; Ariga H
    Genes Cells; 2000 Feb; 5(2):127-41. PubMed ID: 10672043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic activity of the c-Myc protein requires dimerization with Max.
    Amati B; Brooks MW; Levy N; Littlewood TD; Evan GI; Land H
    Cell; 1993 Jan; 72(2):233-45. PubMed ID: 8425220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting miR-21 with NL101 blocks c-Myc/Mxd1 loop and inhibits the growth of B cell lymphoma.
    Li S; He X; Gan Y; Zhang J; Gao F; Lin L; Qiu X; Yu T; Zhang X; Chen P; Tong J; Qian W; Xu Y
    Theranostics; 2021; 11(7):3439-3451. PubMed ID: 33537096
    [No Abstract]   [Full Text] [Related]  

  • 20. Design and properties of a Myc derivative that efficiently homodimerizes.
    Soucek L; Helmer-Citterich M; Sacco A; Jucker R; Cesareni G; Nasi S
    Oncogene; 1998 Nov; 17(19):2463-72. PubMed ID: 9824157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.